Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/934
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBrenu, E Wen_US
dc.contributor.authorHardcastle, S Len_US
dc.contributor.authorAtkinson, G Men_US
dc.contributor.authorvan Driel, M Len_US
dc.contributor.authorKreijkamp-Kaspers, Sen_US
dc.contributor.authorAshton, K Jen_US
dc.contributor.authorStaines, D Ren_US
dc.contributor.authorMarshall-Gradisnik, S Men_US
dc.date.accessioned2019-05-30T02:24:25Z-
dc.date.available2019-05-30T02:24:25Z-
dc.date.issued2013-12-
dc.identifier.citationBrenu, E W et al. “Natural killer cells in patients with severe chronic fatigue syndrome.” Auto- immunity highlights vol. 4,3 69-80. 16 Apr. 2013, doi:10.1007/s13317-013-0051-xen_US
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/934-
dc.description.abstractMaintenance of health and physiological homeostasis is a synergistic process involving tight regulation of proteins, transcription factors and other molecular processes. The immune system consists of innate and adaptive immune cells that are required to sustain immunity. The presence of pathogens and tumour cells activates innate immune cells, in particular Natural Killer (NK) cells. Stochastic expression of NK receptors activates either inhibitory or activating signals and results in cytokine production and activation of pathways that result in apoptosis of target cells. Thus, NK cells are a necessary component of the immunological process and aberrations in their functional processes, including equivocal levels of NK cells and cytotoxic activity pre-empts recurrent viral infections, autoimmune diseases and altered inflammatory responses. NK cells are implicated in a number of diseases including chronic fatigue syndrome (CFS). The purpose of this review is to highlight the different profiles of NK cells reported in CFS patients and to determine the extent of NK immune dysfunction in subtypes of CFS patients based on severity in symptoms.en_US
dc.language.isoenen_US
dc.publisherSpringer-Verlagen_US
dc.relation.ispartofAuto- immunity highlightsen_US
dc.subjectcytotoxicityen_US
dc.subjectperforinen_US
dc.subjectGranzymesen_US
dc.subjectChronic Fatigue Syndromeen_US
dc.subjectNatural Killer Cellsen_US
dc.titleNatural killer cells in patients with severe chronic fatigue syndromeen_US
dc.typeArticleen_US
dc.identifier.doi10.1007/s13317-013-0051-x-
item.fulltextWith Fulltext-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.openairetypeArticle-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Sites:Gold Coast Health Publications
Queensland Health Publications
Files in This Item:
File Description SizeFormat 
s13317-013-0051-x.pdf398.85 kBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

586
checked on May 8, 2025

Download(s)

218
checked on May 8, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.